The AI in genomics market size was valued at $346.3 million in 2021 and is projected to reach $9,859.7 million by 2031, registering a CAGR of 40.6% from 2022 to 2031. North America dominates the global AI in Genomics market, and the machine learning segment is expected to maintain its leadership status throughout the forecast period. The software segment is also expected to maintain its leadership status throughout the forecast period, and the pharmaceutical and biotech companies segment is expected to maintain its lead position during the forecast period. AI applications for genome sequencing and analysis, drug discovery and development, and clinical genomics are the major types of AI applications in the market.